BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29922925)

  • 1. Two-year efficacy of single-session high-intensity focused ultrasound (HIFU) ablation of benign thyroid nodules.
    Lang BHH; Woo YC; Chiu KW
    Eur Radiol; 2019 Jan; 29(1):93-101. PubMed ID: 29922925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of second high-intensity focused ultrasound (HIFU) treatment for unsatisfactory benign thyroid nodules after first treatment.
    Lang BH; Woo YC; Chiu KW
    Eur Radiol; 2019 Mar; 29(3):1469-1478. PubMed ID: 30088067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Session High-Intensity Focused Ultrasound Treatment in Large-Sized Benign Thyroid Nodules.
    Lang BH; Woo YC; Chiu KW
    Thyroid; 2017 May; 27(5):714-721. PubMed ID: 28326895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of hyperechoic marks observed during high-intensity focused ultrasound (HIFU) ablation of benign thyroid nodules.
    Lang BHH; Woo YC; Chiu KW
    Eur Radiol; 2018 Jun; 28(6):2675-2681. PubMed ID: 29313120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two sequential applications of high-intensity focused ultrasound (HIFU) ablation for large benign thyroid nodules.
    Lang BHH; Woo YC; Chiu KW
    Eur Radiol; 2019 Jul; 29(7):3626-3634. PubMed ID: 30778718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-intensity focused ultrasound (HIFU) therapy for benign thyroid nodules: a 3-year retrospective multicenter follow-up study.
    Monpeyssen H; Ben Hamou A; Hegedüs L; Ghanassia É; Juttet P; Persichetti A; Bizzarri G; Bianchini A; Guglielmi R; Raggiunti B; Alamri A; Machuron F; Taverna D; Barbaro D; Papini E
    Int J Hyperthermia; 2020; 37(1):1301-1309. PubMed ID: 33222569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High intensity focused ultrasound (HIFU) ablation of benign thyroid nodule is safe and efficacious in patients who continue taking an anti-coagulation or anti-platelet agent in the treatment period.
    Lang BH; Woo YC; Chiu KW
    Int J Hyperthermia; 2019; 36(1):186-190. PubMed ID: 30556448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential high intensity focused ultrasound (HIFU) ablation in the treatment of benign multinodular goitre: an observational retrospective study.
    Lang BHH; Woo YC; Chiu KW
    Eur Radiol; 2018 Aug; 28(8):3237-3244. PubMed ID: 29556769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Intensity Focused Ultrasound for Treatment of Symptomatic Benign Thyroid Nodules: A Prospective Study.
    Lang BH; Woo YC; Wong CKH
    Radiology; 2017 Sep; 284(3):897-906. PubMed ID: 28419814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The percentage of serum thyroglobulin rise in the first-week did not predict the eventual success of high-intensity focussed ablation (HIFU) for benign thyroid nodules.
    Lang BHH; Woo YC; Chiu KWH
    Int J Hyperthermia; 2017 Dec; 33(8):882-887. PubMed ID: 28793806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining high-intensity focused ultrasound (HIFU) ablation with percutaneous ethanol injection (PEI) in the treatment of benign thyroid nodules.
    Lang BHH; Woo YC; Chiu KW
    Eur Radiol; 2021 Apr; 31(4):2384-2391. PubMed ID: 32974689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of high-intensity focused ultrasound (HIFU) for treating benign thyroid nodules: a systematic review and meta-analysis.
    Chung SR; Baek JH; Suh CH; Choi YJ; Lee JH
    Acta Radiol; 2020 Dec; 61(12):1636-1643. PubMed ID: 32202137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further Investigation on High-intensity Focused Ultrasound (HIFU) Treatment for Thyroid Nodules: Effectiveness Related to Baseline Volumes.
    Sennert M; Happel C; Korkusuz Y; Grünwald F; Polenz B; Gröner D
    Acad Radiol; 2018 Jan; 25(1):88-94. PubMed ID: 28844602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Efficacy and Safety of High-Intensity Focused Ultrasound (HIFU) Therapy for Benign Thyroid Nodules-A Single Center Experience from Singapore.
    Prakash PS; Oh HB; Tan WB; Parameswaran R; Ngiam KY
    World J Surg; 2019 Aug; 43(8):1957-1963. PubMed ID: 30863871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-Month Volume Reduction Ratio Predicts Regrowth and Time to Regrowth in Thyroid Nodules Submitted to Laser Ablation: A 5-Year Follow-Up Retrospective Study.
    Negro R; Greco G; Deandrea M; Rucco M; Trimboli P
    Korean J Radiol; 2020 Jun; 21(6):764-772. PubMed ID: 32410415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-intensity focused ultrasound (HIFU) for benign thyroid nodules: 2-year follow-up results.
    Trimboli P; Pelloni F; Bini F; Marinozzi F; Giovanella L
    Endocrine; 2019 Aug; 65(2):312-317. PubMed ID: 30919288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal ablation of thyroid nodules: are radiofrequency ablation, microwave ablation and high intensity focused ultrasound equally safe and effective methods?
    Korkusuz Y; Gröner D; Raczynski N; Relin O; Kingeter Y; Grünwald F; Happel C
    Eur Radiol; 2018 Mar; 28(3):929-935. PubMed ID: 28894936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in serum thyroglobulin and antithyroglobulin shortly following high-intensity focused ablation of benign thyroid nodules in patients with positive antithyroglobulin status.
    Lang BHH; Woo YC; Chiu KW
    Int J Hyperthermia; 2018; 35(1):637-643. PubMed ID: 30303432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-session high-intensity focused ultrasound (HIFU) ablation for benign thyroid nodules: a systematic review.
    Spartalis E; Karagiannis SP; Plakopitis N; Theodori MA; Chrysikos D; Paschou SA; Boutzios G; Schizas D; Spartalis M; Troupis T; Nikiteas N
    Expert Rev Med Devices; 2020 Aug; 17(8):759-771. PubMed ID: 32749167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictor Analysis in Radiofrequency Ablation of Benign Thyroid Nodules: A Single Center Experience.
    Bisceglia A; Rossetto R; Garberoglio S; Franzin A; Cerato A; Maletta F; Papotti MG; Ghigo E; Pagano L; Maccario M; Garberoglio R
    Front Endocrinol (Lausanne); 2021; 12():638880. PubMed ID: 34079521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.